Cargando…

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study

Globally, Prostate cancer (PCa) is the second most common cancer in the male population worldwide, but clinically significant prostate cancer (CSPCa) is more aggressive and causes to more deaths. The authors aimed to construct the risk category based on Prostate Imaging Reporting and Data System sco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Yin, Li, Tian Jie, Gu, Peng, Yang, Yu kun, Zhao, Lei, Gao, Chao, Hu, Juan, Liu, Xiao Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539128/ https://www.ncbi.nlm.nih.gov/pubmed/36212411 http://dx.doi.org/10.3389/fonc.2022.992032

Ejemplares similares

The Impact of Prostate Imaging Reporting and Data System Version 2.1 and Prostate-Specific Antigen Density in the Prediction of Clinically Significant Prostate Cancer
por: Tezcan, Sehnaz, et al.
Publicado: (2023)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

The use of prostate specific antigen density to predict clinically significant prostate cancer
por: Yusim, Igor, et al.
Publicado: (2020)

Isolated brain metastasis of prostate carcinoma in the setting of normal prostate specific antigen
por: Campagna, Justin P., et al.
Publicado: (2018)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023)

Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis
por: Deng, Xiaobin, et al.
Publicado: (2022)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)

The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review
por: Zhang, Xu, et al.
Publicado: (2023)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
por: Mandel, Philipp, et al.
Publicado: (2021)

Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
por: Kataria, Shaan, et al.
Publicado: (2017)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Inter-reader agreement of the prostate imaging reporting and data system version v2.1 for detection of prostate cancer: A systematic review and meta-analysis
por: Wen, Jing, et al.
Publicado: (2022)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
por: Karnes, R. Jeffrey, et al.
Publicado: (2018)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
por: Nath, Chandan Kumar, et al.
Publicado: (2020)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
por: Kim, Jong Min, et al.
Publicado: (2011)

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022)

Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
por: Nowroozi, Mohammad Reza, et al.
Publicado: (2016)

The Predictive Value of Prostate-Specific Antigen Density: A Retrospective Analysis of Likert 3 Multiparametric MRI of the Prostate
por: Feyisetan, Oladapo, et al.
Publicado: (2023)

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
por: Nitta, Satoshi, et al.
Publicado: (2019)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
por: Hupe, Marie Christine, et al.
Publicado: (2018)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
por: Ganpule, Arvind P., et al.
Publicado: (2007)

Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer
por: Zhou, Yongheng, et al.
Publicado: (2022)

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
por: Udeh, Emeka I., et al.
Publicado: (2016)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qd4uvagt4bp7jr2eatf5v1hij0